Global Vaccine for Influenza Market Research Report 2024(Status and Outlook)

Global Vaccine for Influenza Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Vaccine for Influenza Market Size was estimated at USD 5690.45 million in 2023 and is projected to reach USD 7846.24 million by 2029, exhibiting a CAGR of 5.50% during the forecast period.

This report provides a deep insight into the global Vaccine for Influenza market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine for Influenza Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine for Influenza market in any manner.

Global Vaccine for Influenza Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi

CSL

GSK

Viatris

AstraZeneca

Hualan Bio

Changchun Institute of Biological

Sinovac

BCHT

Jiangsu GDK

KM Biologics

Market Segmentation (by Type)

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Market Segmentation (by Application)

6 Months to 3 Years

> 3 Years

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Vaccine for Influenza Market
  • Overview of the regional outlook of the Vaccine for Influenza Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine for Influenza Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Vaccine for Influenza
1.2 Key Market Segments
1.2.1 Vaccine for Influenza Segment by Type
1.2.2 Vaccine for Influenza Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Vaccine for Influenza Market Overview
2.1 Global Market Overview
2.1.1 Global Vaccine for Influenza Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Vaccine for Influenza Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Vaccine for Influenza Market Competitive Landscape
3.1 Global Vaccine for Influenza Sales by Manufacturers (2019-2024)
3.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2019-2024)
3.3 Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaccine for Influenza Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vaccine for Influenza Sales Sites, Area Served, Product Type
3.6 Vaccine for Influenza Market Competitive Situation and Trends
3.6.1 Vaccine for Influenza Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaccine for Influenza Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Vaccine for Influenza Industry Chain Analysis
4.1 Vaccine for Influenza Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Vaccine for Influenza Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Vaccine for Influenza Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine for Influenza Sales Market Share by Type (2019-2024)
6.3 Global Vaccine for Influenza Market Size Market Share by Type (2019-2024)
6.4 Global Vaccine for Influenza Price by Type (2019-2024)
7 Vaccine for Influenza Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine for Influenza Market Sales by Application (2019-2024)
7.3 Global Vaccine for Influenza Market Size (M USD) by Application (2019-2024)
7.4 Global Vaccine for Influenza Sales Growth Rate by Application (2019-2024)
8 Vaccine for Influenza Market Segmentation by Region
8.1 Global Vaccine for Influenza Sales by Region
8.1.1 Global Vaccine for Influenza Sales by Region
8.1.2 Global Vaccine for Influenza Sales Market Share by Region
8.2 North America
8.2.1 North America Vaccine for Influenza Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vaccine for Influenza Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vaccine for Influenza Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vaccine for Influenza Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vaccine for Influenza Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Sanofi
9.1.1 Sanofi Vaccine for Influenza Basic Information
9.1.2 Sanofi Vaccine for Influenza Product Overview
9.1.3 Sanofi Vaccine for Influenza Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Vaccine for Influenza SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 CSL
9.2.1 CSL Vaccine for Influenza Basic Information
9.2.2 CSL Vaccine for Influenza Product Overview
9.2.3 CSL Vaccine for Influenza Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Vaccine for Influenza SWOT Analysis
9.2.6 CSL Recent Developments
9.3 GSK
9.3.1 GSK Vaccine for Influenza Basic Information
9.3.2 GSK Vaccine for Influenza Product Overview
9.3.3 GSK Vaccine for Influenza Product Market Performance
9.3.4 GSK Vaccine for Influenza SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Viatris
9.4.1 Viatris Vaccine for Influenza Basic Information
9.4.2 Viatris Vaccine for Influenza Product Overview
9.4.3 Viatris Vaccine for Influenza Product Market Performance
9.4.4 Viatris Business Overview
9.4.5 Viatris Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Vaccine for Influenza Basic Information
9.5.2 AstraZeneca Vaccine for Influenza Product Overview
9.5.3 AstraZeneca Vaccine for Influenza Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Hualan Bio
9.6.1 Hualan Bio Vaccine for Influenza Basic Information
9.6.2 Hualan Bio Vaccine for Influenza Product Overview
9.6.3 Hualan Bio Vaccine for Influenza Product Market Performance
9.6.4 Hualan Bio Business Overview
9.6.5 Hualan Bio Recent Developments
9.7 Changchun Institute of Biological
9.7.1 Changchun Institute of Biological Vaccine for Influenza Basic Information
9.7.2 Changchun Institute of Biological Vaccine for Influenza Product Overview
9.7.3 Changchun Institute of Biological Vaccine for Influenza Product Market Performance
9.7.4 Changchun Institute of Biological Business Overview
9.7.5 Changchun Institute of Biological Recent Developments
9.8 Sinovac
9.8.1 Sinovac Vaccine for Influenza Basic Information
9.8.2 Sinovac Vaccine for Influenza Product Overview
9.8.3 Sinovac Vaccine for Influenza Product Market Performance
9.8.4 Sinovac Business Overview
9.8.5 Sinovac Recent Developments
9.9 BCHT
9.9.1 BCHT Vaccine for Influenza Basic Information
9.9.2 BCHT Vaccine for Influenza Product Overview
9.9.3 BCHT Vaccine for Influenza Product Market Performance
9.9.4 BCHT Business Overview
9.9.5 BCHT Recent Developments
9.10 Jiangsu GDK
9.10.1 Jiangsu GDK Vaccine for Influenza Basic Information
9.10.2 Jiangsu GDK Vaccine for Influenza Product Overview
9.10.3 Jiangsu GDK Vaccine for Influenza Product Market Performance
9.10.4 Jiangsu GDK Business Overview
9.10.5 Jiangsu GDK Recent Developments
9.11 KM Biologics
9.11.1 KM Biologics Vaccine for Influenza Basic Information
9.11.2 KM Biologics Vaccine for Influenza Product Overview
9.11.3 KM Biologics Vaccine for Influenza Product Market Performance
9.11.4 KM Biologics Business Overview
9.11.5 KM Biologics Recent Developments
10 Vaccine for Influenza Market Forecast by Region
10.1 Global Vaccine for Influenza Market Size Forecast
10.2 Global Vaccine for Influenza Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Vaccine for Influenza Market Size Forecast by Country
10.2.3 Asia Pacific Vaccine for Influenza Market Size Forecast by Region
10.2.4 South America Vaccine for Influenza Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Vaccine for Influenza by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Vaccine for Influenza Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Vaccine for Influenza by Type (2025-2030)
11.1.2 Global Vaccine for Influenza Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Vaccine for Influenza by Type (2025-2030)
11.2 Global Vaccine for Influenza Market Forecast by Application (2025-2030)
11.2.1 Global Vaccine for Influenza Sales (Kilotons) Forecast by Application
11.2.2 Global Vaccine for Influenza Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings